Anticancer Research
-
Publication Venue For
- Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer.. 40:1459-1462. 2020
- Transperitoneal Versus Extraperitoneal Laparoscopic Lymphadenectomy for Gynecological Malignancies: A Systematic Review and Meta-analysis.. 38:4677-4681. 2018
- The "Yin and Yang" of Platelet-rich Plasma in Breast Reconstruction After Mastectomy or Lumpectomy for Breast Cancer.. 37:6557-6562. 2017
- Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.. 37:2185-2194. 2017
- Comprehensive Surgical Treatment as the Mainstay of Management in Retroperitoneal Sarcomas: Retrospective Study from Two Non-sarcoma Specialist Centers.. 37:2025-2031. 2017
- De Novo Renal Cell Carcinoma of Native Kidneys in Renal Transplant Recipients: A Single-center Experience.. 37:773-779. 2017
- Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.. 37:35-46. 2017
- Minimally Invasive Lymphadenectomy in Uterine Cervical Cancer: A Systematic Review.. 37:335-342. 2017
- Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes.. 37:9-14. 2017
- Effect of a metalloporphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation.. 29:107-118. 2009
- GENETIC PROFILING IN TUMOR XENOGRAFTS FROM PAEDIATRIC GLIOMAS BY EXPRESSION AND HIGH RESOLUTION COMPARATIVE GENOMIC HYBRIDISATION MICROARRAYS. 28:3341-3341. 2008
- MALIGNANT GROWTH IN THE BONE MARROW CREATES ABNORMAL HEMATOPOIETIC PROGENITOR CELL NICHES. 28:3555-3555. 2008
- Photodynamic therapy of Barrett's esophagus: ablation of Barrett's mucosa and reduction in p53 protein expression after treatment.. 28:485-489. 2008
- Radiolabelling of glucose-Tyr3-octreotate with 125I and analysis of its metabolism in rats: comparison with radiolabelled DOTA-Tyr3-octreotate.. 27:3941-3946. 2007
- Radiolabelling of glucose-Tyr3 -octreotate with 125 I and analysis of its metabolism in rats: Comparison with radiolabelled DOTA-Tyr3 -octreotate. 27:3941-3946. 2007
- Radiation and a metalloporphyrin radioprotectant in a mouse prostate tumor model. 27:3101-3109. 2007
- Radiation and a metalloporphyrin radioprotectant in a mouse prostate tumor model.. 27:3101-3109. 2007
- Gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients with advanced biliary tree cancers: a pilot study.. 26:771-775. 2006
- Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line.. 25:1-8. 2005
- p63 expression profile in normal and malignant prostate epithelial cells.. 22:3819-3825. 2002
- Heat shock protein 70 (HSP70) does not prevent the inhibition of cell growth in DU-145 cells treated with TGF-beta1.. 21:3341-3347. 2001
- Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer. 21:1241-1246. 2001
- Effects of 10-hydroxycamptothecin, delivered from locally injectable poly(lactide-co-glycolide) microspheres, in a murine human oral squamous cell carcinoma regression model.. 21:1713-1722. 2001
- Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer.. 21:1241-1246. 2001
- Complex response of breast epithelial cell lines to topoisomerase inhibitors.. 18:2919-2932. 1998
- Molecular characterization of the human delta opioid receptor in lung cancer.. 18:1787-1792. 1998
- Molecular characterization of the human δ opioid receptor in lung cancer. 18:1787-1792. 1998
- Growth inhibition of a human lung adenocarcinoma cell line by genetic complementation with chromosome 11.. 17:3243-3251. 1997
- Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.. 17:795-801. 1997
- Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer. 17:795-801. 1997
- Discrimination between tumour and normal cells by staining with 3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19α-methyl-20α -oxayohimbanium: The uracil ring as a target for the specific interaction between RNA(s) and the fluorescent probe. 16:1881-1886. 1996
- Tumor oxygenation: a matter of supply and demand.. 16:741-749. 1996
- The synthetic phosphagen cyclocreatine phosphate inhibits the growth of a broad spectrum of solid tumors.. 16:375-380. 1996
- Somatic mutations in the neurofibromatosis 1 gene in gliomas and primitive neuroectodermal tumours. 15:2495-2499. 1995
- Somatic mutations in the neurofibromatosis 1 gene in gliomas and primitive neuroectodermal tumours.. 15:2495-2499. 1995
- Antiproliferative effects of cyclocreatine on human prostatic carcinoma cells.. 15:1339-1342. 1995
- Modulation of cisplatin resistance by 2'-deoxy-5-azacytidine in human ovarian tumor cell lines.. 14:247-251. 1994
- p53 gene mutation spectrum in human unknown primary tumors.. 13:1619-1623. 1993
- Antineoplastic activity of boron-containing thymidine nucleosides in Tmolt3 leukemic cells.. 12:1091-1097. 1992
- The synthesis and antineoplastic activity of 2'-deoxy-nucleoside-cyanoboranes in murine and human culture cells.. 12:335-343. 1992
- DNA interstrand crosslinking and strand break repair in human glioma cell lines of varying [1,3-bis(2-chloroethyl)-1-nitrosourea] resistance.. 10:677-682. 1990
- Effect of epidermal growth factor on ornithine decarboxylase activity in A431 cells.. 9:209-213. 1989
- Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis.. 4:133-140. 1984